Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: Use of an optimized procedure for the coupling of low concentrations of antibody to liposomes

Journal of Liposome Research

Volumn 21, Issue 2, 2011, Pages 95-105

  Hua, Susan ^a   Chang, Hsin I ^a   Davies, Nigel M ^a   Cabot, Peter J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Inflammation

Indexed keywords

DRUG CARRIER; IMMUNOGLOBULIN G; IMMUNOLIPOSOME; INTERCELLULAR ADHESION MOLECULE 1; LIPOSOME; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TARGETING; DRUG UPTAKE; ENDOTHELIUM CELL; FLUORESCENCE SPECTROSCOPY; INFLAMMATION; INTERNALIZATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIPOSOMES; LYMPH NODES; MICROSCOPY, FLUORESCENCE; MOLECULAR TARGETED THERAPY; RABBITS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956084466     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982101003754401     Document Type: Article

References (50)

1. Adamson, P., Etienne, S., Couraud, P. O., Calder, V., Greenwood, J. (1999). Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol 162:2964-2973. (Pubitemid 29309325)
2. Ager, A. (1987). Isolation and culture of high endothelial cells from rat lymph nodes. J Cell Sci 87:133-144. (Pubitemid 17012882)
3. Almenar-Queralt, A., Duperray, A., Miles, L. A., Felez, J., Altieri, D. C. (1995). Apical topography and modulation of ICAM-1 expression on activated endothelium. Am J Pathol 147:1278-1288.
4. Badiee, A., Davies, N., McDonald, K., Radford, K., Michiue, H., Hart, D., et al. (2007). Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor, DEC-205. Vaccine 207:4757-4766. (Pubitemid 46818617)
5. Bendas, G. (2001). Immunoliposomes: a promising approach to targeting cancer therapy. BioDrugs 15:215-224.
6. Bloemen, P. G., Henricks, P. A., van Bloois, L., van den Tweel, M. C., Bloem, A. C., Nijkamp, F. P., et al. (1995). Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett 357:140-144.
7. Carpen, O., Pallai, P., Staunton, D. E., Springer, T. A. (1992). Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. J Cell Biol 118:1223-1234.
8. Ding, B. S., Dziubla, T., Shuvaev, V. V., Muro, S., Muzykantov, V. R. (2006). Advanced drug delivery systems that target the vascular endothelium. Mol Interv 6:98-112.
9. Durieu-Trautmann, O., Chaverot, N., Cazaubon, S., Strosberg, S. D., Couraud, P. O. (1994). Intercellular adhesion molecule-1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem 269:12536-12540.
10. Etienne-Manneville, S., Manneville, J. B., Adamson, P., Wilbourn, B., Greenwood, J., Couraud, P. O. (2000). ICAM-1-coupled cytoskeletal rearrangments and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol 165:3375-3383.
11. Everts, M., Koning, G. A., Kok, R. J., Asgeirsdottir, S. A., Vestweber, D., Meijer, D. K., et al. (2003). In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium. Pharm Res 20:64-72. (Pubitemid 36152919)
12. Goundalkar, A., Ghose, T., Mezei, M. (1984). Covalent binding of antibodies to liposomes using a novel lipid derivative. J Pharm Pharmacol 36:465-466. (Pubitemid 14076437)
13. Han, J. C., Han, G. Y. (1994). A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol. Anal Biochem 220:5-10.
14. Heath, T. D., Martin, F. J. (1986). The development and application of protein-liposome conjugation techniques. Chem Phys Lipids 40:347-358.
15. Heiska, L., Alfthan, K., Gronholm, M., Vilja, P., Vaheri, A., Carpen, O. (1998). Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4,5-bisphosphate. J Biol Chem 273:21893-21900. (Pubitemid 28405367)
16. Hubbard, A. K., Rothlein, R. (2000). Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28:1379-1386. (Pubitemid 30623498)
17. Jaafari, M. R., Foldvari, M. (2002). Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains. J Pharm Sci 91:396-404. (Pubitemid 34137361)
18. Janssen, A. P., Schiffelers, R. M., ten Hagen, T. L., Koning, G. A., Schraa, A. J., Kok, R. J., et al. (2003). Peptide-targeted PEGliposomes in antiangiogenic therapy. Int J Pharm 254:55-58.
19. Kessner, S., Krause, A., Rothe, U., Bendas, G. (2001). Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells. Biochim Biophys Acta 1514:177-190. (Pubitemid 32831007)
20. Koning, G. A., Schiffelers, R. M., Storm, G. (2002). Endothelial cells at inflammatory sites as target for therapeutic intervention. Endothelium 9:161-171. (Pubitemid 35021586)
21. Kuijpers, T. W., Raleigh, M., Kavanagh, T., Janssen, H., Calafat, J., Roos, D., et al. (1994). Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. J Immunol 152:5060-5069. (Pubitemid 24139101)
22. Lopes de Menezes, D. E., Pilarski, L. M., Allen, T. M. (1998). In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res 58:3320-3330. (Pubitemid 28371072)
23. Martin, F. J., Hubell, W. L., Papahadjopoulos, D. (1981). Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulphide bonds. Biochemistry 20:4229-4238.
24. Martin, F. J., Papahadjopoulos, D. (1982). Irreversible coupling of immunoglobulin fragments to preformed vesicles. J Biol Chem 257:286-288.
25. Maruyama, K. (2002). PEG-immunoliposome. Biosci Rep 22:251-266. (Pubitemid 35222734)
26. Mastrobattista, E., Koning, G. A., Storm, G. (1999a). Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev 40:103-127. (Pubitemid 29486607)
27. Mastrobattista, E., Storm, G., van Bloois, L., Reszka, R., Bloemen, P. G., Crommelin, D. J., et al. (1999b). Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochim Biophys Acta 1419:353-363. (Pubitemid 29322725)
28. Metselaar, J. M., Storm, G. (2005). Liposomes in the treatment of inflammatory disorders. Exp Opin Drug Deliv 2:465-476. (Pubitemid 41683222)
29. Metselaar, J. M., Wauben, M. H., Wagenaar-Hilbers, J. P., Boerman, O. C., Storm, G. (2003). Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthr Rheum 48:2059-2066. (Pubitemid 36828702)
30. Mojcik, C. F., Shevach, E. M. (1997). Adhesion molecules: a rheumatologic perspective. Arthr Rheum 40:991-1004. (Pubitemid 27242285)
31. Murciano, J. C., Muro, S., Koniaris, L., Christofidou-Solomidou, M., Harshaw, D. W., Albelda, S. M., et al. (2003). ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood 101:3977-3984. (Pubitemid 36857875)
32. Muro, S., Dziubla, T., Qiu, W., Leferovich, J., Cui, X., Berk, E. (2006a). Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. Pharmacol Exp Ther 317:1161-1169. (Pubitemid 43764121)
33. Muro, S., Gajewski, C., Koval, M., Muzykantov, V. R. (2005). ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood 105:650-658. (Pubitemid 40070749)
34. Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., et al. (2008). Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 16:1450-1458.
35. Muro, S., Koval, M., Muzykantov, V. (2004). Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol 2:281-299. (Pubitemid 38855034)
36. Muro, S., Mateescu, M., Gajewski, C., Robinson, M., Muzykantov, V. R., Koval, M. (2006b). Control of intracellular trafficking of ICAM-1-targeted nano carriers by endothelial Na+/H+ exchanger proteins. Am J Physiol Lung Cell Mol Physiol 290:L809-L817. (Pubitemid 43725041)
37. Muro, S., Muzykantov, V. R. (2005). Targeting of antioxidant and antithrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des 11:2383-2401. (Pubitemid 40872703)
38. Muro, S., Wiewrodt, R., Thomas, A., Koniaris, L., Albelda, S. M., Muzykantov, V. R., et al. (2003). A novel end ocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 116:1599-1609. (Pubitemid 36527505)
39. Scholz, D., Devaux, B., Hirche, A., Potzsch, B., Kropp, B., Schaper, W., et al. (1996). Expression of adhesion molecules is specific and time dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res 284:415-423. (Pubitemid 26166738)
40. Senior, J. H. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst 3:123-193. (Pubitemid 17219201)
41. Simone, E., Ding, D. S., Muzykantov, V. R. (2009). Targeted delivery of therapeutics to endothelium. Cell Tissue Res 335:283-300.
42. Spragg, D. D., Alford, D. R., Greferath, R., Larsen, C. E., Lee, K. D., Gurtner, G. C., et al. (1997). Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci USA 94:8795-8800. (Pubitemid 27335119)
43. Torchilin, V. P. (1994). Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents. Mmunomethods 4:244-258. (Pubitemid 24318708)
44. Torchilin, V. P. (1996). Affinity liposomes in vivo: factors influencing target accumulation. J Mol Recog 9:335-346. (Pubitemid 126446977)
45. Ulrich, A. S. (2002). Biophysical aspects of using liposomes as delivery vehicles. Biosci Rep 22:129-150. (Pubitemid 35222729)
46. Villanueva, F. S., Jankowski, R. J., Klibanov, S., Pina, M. L., Alber, S. M., Watkins, S. C. (1998). Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98:1-5. (Pubitemid 28312070)
47. Vingerhoeds, M. H., Storm, G., Crommelin, D. J. (1994). Immunoliposomes in vivo. Mmunomethods 4:259-272. (Pubitemid 24318709)
48. Voinea, M., Manduteanu, I., Dragomir, E., Capraru, M., Simionescu, M. (2005). Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells-a potential tool for specific drug delivery. Pharm Res 22:1906-1917. (Pubitemid 41504344)
49. Willis, M., Forssen, E. (1998). Ligand-targeted liposomes. Adv Drug Deliv Rev 29:249-271. (Pubitemid 28090045)
50. Wolff, B., Gregoriadis, G. (1984). The use of monoclonal anti-Thy 1 IgG1 for the targeting of liposomes to AKR-A cells in vitro and in vivo. Biochim Biophys Acta 802:259-273. (Pubitemid 15214114)